Soleus Capital Management, L.P. Amicus Therapeutics, Inc. Transaction History

Soleus Capital Management, L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$11.43 - $14.24 $662,551 - $825,435	57,966 New	57,966 $682,000
Q3 2020 Nov 13, 2020	SELL	$12.89 - $15.89 $1.64 Million - $2.02 Million	-127,300 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$8.86 - $15.69 $489,957 - $867,657	55,300 Added 76.81%	127,300 $1.92 Million
Q1 2020 May 15, 2020	SELL	$6.63 - $11.16 $774,384 - $1.3 Million	-116,800 Reduced 61.86%	72,000 $665,000
Q4 2019 Feb 14, 2020	BUY	$7.48 - $10.75 $1.41 Million - $2.03 Million	188,800 New	188,800 $1.84 Million

311

314M

516K

833K

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.53B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

Get notified when there are updates to the investment portfolio of Soleus Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Soleus Capital Management, L.P. with notifications on news.